Advaxis Director Purchases $50,000 in Stock (ADXS)
Advaxis (NASDAQ:ADXS) Director Roni Appel purchased 12,500 shares of the company’s stock on the open market in a transaction that occurred on Thursday, October 24th. The shares were purchased at an average cost of $4.00 per share, for a total transaction of $50,000.00. Following the transaction, the director now directly owns 57,023 shares in the company, valued at approximately $228,092. The acquisition was disclosed in a filing with the SEC, which is available at this link.
Shares of Advaxis (NASDAQ:ADXS) traded up 3.75% on Tuesday, hitting $3.87. 516,335 shares of the company’s stock traded hands. Advaxis has a one year low of $2.60 and a one year high of $20.00. The stock’s 50-day moving average is $3.6 and its 200-day moving average is $6.82. The company’s market cap is $45.6 million.
Advaxis, Inc is a development-stage biotechnology company with the focus on developing cancer vaccines that utilize multiple mechanisms of immunity.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.